New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands

Journal of Inorganic Biochemistry

Volumn 109, Issue , 2012, Pages 72-81

  Grau, Jordi ^a   Noe, Verónica ^a   Ciudad, Carles ^a   Prieto, Maria J ^a   Font Bardia, Mercè ^a   Calvet, Teresa ^a   Moreno, Virtudes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

AFM; Arene ruthenium(II) complexes; pBR322 plasmid DNA; Ruthenium antitumor compounds; Ruthenium compound DNA binding

Indexed keywords

ANILINE DERIVATIVE; ANTINEOPLASTIC AGENT; ETHIDIUM BROMIDE; PLASMID DNA; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PYRIDINE DERIVATIVE; RUCL2(P CYM)(1,4 METHYLAMINOBENZENE); RUCL2(P CYM)(3,4 DIMETHYLPYRIDINE); RUCL2(P CYM)(4 METHYLPYRIDINE); RUTHENIUM COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL CULTURE; CIRCULAR DICHROISM; COLON ADENOCARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYCLIC POTENTIOMETRY; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG SYNTHESIS; ELECTROPHORESIS; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; OXIDATION REDUCTION POTENTIAL; PANCREAS CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY; VISCOSITY;

ANTINEOPLASTIC AGENTS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CELL SURVIVAL; CIRCULAR DICHROISM; COORDINATION COMPLEXES; DNA; ELECTROCHEMICAL TECHNIQUES; ETHIDIUM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ATOMIC FORCE; MODELS, MOLECULAR; OXIDATION-REDUCTION; PYRIDINES; RUTHENIUM; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VISCOSITY;

EID: 84857541750     PISSN: 01620134     EISSN: 18733344     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2012.01.003     Document Type: Article

References (39)

1. T. Boulikas, M. Vougiouka, Oncol. Rep. 10 (2003) 1663-1682.
2. M. Galanski, V.B. Arion, M.A. Jakupec, B.K. Keppler, Curr. Pharm. Des. 9 (2003) 2078-2089.
3. E. Wong, C.M. Giandomenico, Chem. Rev. 99 (1999) 2451-2466.
4. R.A. Alderden, M.D. Hall, T.W. Hambley, J. Chem. Educ. 83 (2006) (728-null).
5. J. Reedijk, Eur. J. Inorg. Chem. 2009 (2009) 1303-1312.
6. J. Fischer, C.R. Ganellin, Analogue-Based Drug Discovery II, Wiley-VCH, Weinheim, 2006 pp 385-394.
7. R. Agarwal, S.B. Kaye, Nat. Rev. Cancer 3 (2003) 502-516.
8. M.A. Fuertes, C. Alonso, J.M. Perez, Chem. Rev. 103 (2003) 645-662.
9. P.C. Bruijnincx, P.J. Sadler, Curr. Opin. Chem. Biol. 12 (2008) 197-206.
10. C.G. Hartinger, S. Zorbas-Seifried, M.A. Jakupec, B. Kynast, H. Zorbas, B.K. Keppler, J. Inorg. Biochem. 100 (2006) 891-904.
11. J.M. Rademaker-Lakhai, D. van den Bongard, D. Pluim, J.H. Beijnen, J.H. Schellens, Clin. Cancer Res. 10 (2004) 3717-3727.
12. C.S. Allardyce, A. Dorcier, C. Scolaro, P.J. Dyson, Appl. Organomet. Chem. 19 (2005) 1-10.
13. E. Alessio, G. Mestroni, A. Bergamo, G. Sava, Curr. Top. Med. Chem. 4 (2004) 1525-1535.
14. P.J. Dyson, G. Sava, Dalton Trans. (2006) 1929-1933.
15. A.H. Velders, H. Kooijman, A.L. Spek, J.G. Haasnoot, D. de Vos, J. Reedijk, Inorg. Chem. 39 (2000) 2966-2967.
16. W.H. Ang, P.J. Dyson, Eur. J. Inorg. Chem. 2006 (2006) 3993.
17. V. Moreno, M. Font-Bardia, T. Calvet, J. Lorenzo, F.X. Aviles, M.H. Garcia, T.S. Morais, A. Valente, M.P. Robalo, J. Inorg. Biochem. 105 (2011) 241-249.
18. V. Moreno, J. Lorenzo, F.X. Aviles, M.H. Garcia, J.P. Ribeiro, T.S. Morais, P. Florindo, M.P. Robalo, Bioinorg. Chem. Appl. 2010 (2010) 11, Article ID 936834.
19. Y.K. Yan, M. Melchart, A. Habtemariam, P.J. Sadler, Chem. Commun. (Camb.) (2005) 4764-4776.
20. G. Süss-Fink, Dalton Trans. 39 (2010) 1673-1688.
21. W.H. Ang, E. Daldini, C. Scolaro, R. Scopelliti, L. Juillerat-Jeannerat, P.J. Dyson, Inorg. Chem. 45 (2006) 9006-9013.
22. M. Hanif, S.M. Meier, W. Kandioller, A. Bytzek, M. Hejl, C.G. Hartinger, A.A. Nazarov, V.B. Arion, M.A. Jakupec, P.J. Dyson, B.K. Keppler, J. Inorg. Biochem. 105 (2011) 224-231.
23. A.K. Renfrew, A.D. Phillips, A.E. Egger, C.G. Hartinger, S.S. Bosquain, A.A. Nazarov, B.K. Keppler, L. Gonsalvi, M. Peruzzini, P.J. Dyson, Organometallics 28 (2009) 1165-1172.
24. Y.P. Ho, S.C. Au-Yeung, K.K. To, Med. Res. Rev. 23 (2003) 633-655.
25. B. Lippert, Cisplatin: Chemistry and Biochemistry of a Leading Anticancer drugEd, Verlag Helvetica Chimica Acta, Wiley-VCH, Zürich-Weinheim; New York, 1999.
26. J.G. Malecki, M. Jaworska, R. Kruszynski, Polyhedron 25 (2006) 2519-2524.
27. T. Mosmann, J. Immunol. Methods 65 (1983) 55-63.
28. N.G. Connelly, W.E. Geiger, Chem. Rev. 96 (1996) 877-910.
29. I. Bratsos, D. Urankar, E. Zangrando, P. Genova-Kalou, J. Kosmrlj, E. Alessio, I. Turel, Dalton Trans. 40 (2011) 5188-5199.
30. K.N. Kumar, G. Venkatachalam, R. Ramesh, Y. Liu, Polyhedron 27 (2008) 157-166.
31. U. Beck, W. Hummel, H.B. Buergi, A. Ludi, Organometallics 6 (1993) 20.
32. F.B. McCormick, D.D. Cox, W.B. Gleason, Organometallics 12 (1993) 610-612.
33. V.I. Ivanov, L.E. Minchenkova, A.K. Schyolkina, A.I. Poletayev, Biopolymers 12 (1973) 89-110.
34. P. Lincoln, E. Tuite, B. Nordén, J. Am. Chem. Soc. 119 (1997) 1454-1455.
35. J.B. LePecq, C. Paoletti, J. Mol. Biol. 27 (1967) 87-106.
36. T. Biver, F. Secco, M.R. Tine, M. Venturini, J. Inorg. Biochem. 98 (2004) 33-40.
37. M. Mendoza-Ferri, C.G. Hartinger, R.E. Eichinger, N. Stolyanova, K. Severin, M.A. Jakupec, A.A. Nazarov, B.K. Keppler, Organometallics 27 (2008) 2405-2407.
38. M. Gras, B. Therrien, G. Süss-Fink, O. Zava, P.J. Dyson, Dalton Trans. 39 (2010) 10305-10313.
39. M.H. García, T.S. Morais, P. Florido, M.F.M. Piedade, V. Moreno, C. Ciudad, V. Noe, J. Inorg. Biochem. 103 (2009) 354-361.